Benefit from cutting-edge catch & release technology and enable the manufacture of the most complex peptide-based modalities like antibody-drug conjugates, macrocyclic peptides, radio-labeled peptides, or peptide nucleic acids (PNA) to develop the ideal drug or therapy.
|Modalities||Synthetic peptide-based new modalities
|Throughput||Product sample for validation|
|Scale||mg (upscaling upon request)|
|Deliverable||Performance report and product sample for validation
With the new modalities service, we were able to generate a high-quality antibody-bioconjugate modification to a precise specification. With a deep expertise in chemistry and an agile collaborative approach, the PECS team managed the project perfectly and with tremendous insight to help develop the concept. This result has changed the way we think about protein modification and created new opportunities for innovation.
James Schouten, Global Access Diagnostics
Contact our team of experts, and we will help you to enable the manufacturing of most complex peptide-based modalities for the ideal drug or therapy.